SEAL Hemostatic Wound Spray from BC3 Technologies is designed to meet the challenges of arterial bleeding. When sprayed on a wound and upon contact with blood or exudate, SEAL quickly forms a strong ...
Baltimore, MD (3/22/2023) — BC3 Technologies, a privately held medical device company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its SEAL Hemostatic ...
Arterial ulcers and venous ulcers are chronic wounds with different causes and appearances. Arterial ulcers occur due to arterial disease. Venous ulcers develop as a consequence of chronic venous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback